Abstract
Keywords
Get full access to this article
View all access options for this article.
References
1.
Bradford P.A.
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001 ; 14 : 933 –51 .
2.
Li P.K.
,
Szeto C.C.
,
Piraino B.
,
Bernardini J.
,
Figueiredo A.E.
,
Gupta A.
Peritoneal dialysis–related infections recommendations: 2010 update. Perit Dial Int 2010 ; 30 : 393 –423 .
3.
Yip T.
,
Tse K.C.
,
Lam M.F.
,
Tang S.
,
Li F.K.
,
Choy B.Y.
Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients. Perit Dial Int 2006 ; 26 : 191 –7 .
4.
Kang C.I.
,
Kim S.H.
,
Park W.B.
,
Lee K.D.
,
Kim H.B.
,
Oh M.D.
Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Korean J Intern Med 2004 ; 19 : 160 –4 .
5.
Yang C.C.
,
Chuang F.R.
,
Hsu K.T.
,
Chen J.B.
,
Lee C.H.
,
Lee C.T.
Expanded-spectrum beta-lactamase producing Klebsiella pneumoniae- related peritonitis in a patient on peritoneal dialysis. Am J Kidney Dis 2004 ; 44 : e102 –6 .